首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1461327

全球非鴉片類疼痛治療市場，依藥物類型、適應症、給藥配銷通路、通路、地理位置

Global Non Opioid Pain Treatment Market, By Drug Type, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球非鴉片類疼痛治療市場價值為788.9億美元，預計到2031年將達到1405.6億美元，2024年至2031年年複合成長率(CAGR)為8.6%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	788.9 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	8.60%	2030/2031 價值預測：	1405.6 億美元

全球非鴉片類疼痛治療市場佔有率 (%)（依地區），2024 年

慢性疼痛疾病盛行率的上升以及對開發更安全的鴉片類鎮痛藥替代品的關注正在推動全球非鴉片類疼痛治療市場的成長。老年人口不斷增加，更容易患關節炎和其他關節疾病，癌症和相關疼痛的高發病率，以及推動新療法研究和開發的有利監管環境等因素預計將增加對非鴉片類藥物的需求。然而，一旦主要品牌的專利到期，學名藥替代品的可用性等因素可能會阻礙老牌企業的收入成長。

市場動態：

全球非鴉片類疼痛治療市場的成長是由以下因素推動的：人們對長期使用鴉片類藥物、重複性壓力損傷和其他與工作相關的肌肉骨骼疾病的風險認知不斷提高，以及止痛藥物開發商和醫療器材公司之間的策略合作不斷加強。然而，新型藥物輸送系統的開發成本較高，且與鴉片類藥物相比療效較低，可能會阻礙市場成長。人們越來越關注先進藥物配方、聯合療法和神經刺激設備的開發，為該行業的主要參與者提供了利潤豐厚的機會。

研究的主要特點：

該報告對全球非鴉片類疼痛治療市場進行了深入分析，並提供了預測期（2024-2031）的市場規模和年複合成長率（CAGR%），以2023年為基準年。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球非鴉片類疼痛治療市場的主要參與者。
本研究涵蓋的主要公司包括輝瑞公司、梯瓦製藥工業有限公司、Dr. Reddy's Laboratories Ltd.、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、Fresenius Kabi AG、GSK、Vertex Pharmaceuticals Incorporated、Pacira BioSciences 、legium Pharmaceuticals、 Cara Therapeutics、Akelos、Fidia Farmaceutici SpA、賽諾菲、禮來公司、默克公司和Acorda Therapeutics。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球非鴉片類疼痛治療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球非鴉片類疼痛治療市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 9 章：公司簡介 - 全球非鴉片類疼痛治療市場

Pfizer Inc.
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Fresenius Kabi AG
GSK
Vertex Pharmaceuticals Incorporated
Pacira BioSciences
Collegium Pharmaceuticals
Cara Therapeutics
Akelos
Fidia Farmaceutici SpA
Sanofi
Eli Lilly and Company
Merck & Co
Acorda Therapeutics
Hyloris Pharmaceuticals
Hikma Pharmaceuticals PLC

第 10 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6741

Global non opioid pain treatment market is estimated to be valued at USD 78.89 billion in 2024 and is expected to reach USD 140.56 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 78.89 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.60%	2030/2031 Value Projection:	US$ 140.56 Bn

Global Non Opioid Pain Treatment Market Share (%), By Region, 2024

Global Non Opioid Pain Treatment Market - IMG1

Rising prevalence of chronic pain disorders and increasing focus toward developing safer alternatives to opioid analgesics are driving the global non opioid pain treatment market growth. Factors such as growing geriatric population who are more prone to arthritis and other joint disorders, high incidence of cancer and associated pain, and favorable regulatory environment providing a push to research and development of novel therapies are expected to boost demand for non opioid medications. However, factors such as the availability of generic substitutes once patents of major brands expire can hamper the revenue growth of established players.

Market Dynamics:

Global non opioid pain treatment market growth is driven by factors such as growing awareness about risks of long term opioid usage, repetitive stress injuries and rising other work related musculoskeletal disorders, and increasing strategic collaborations between pain drug developers and medical device companies. However, high development cost of novel drug delivery systems and perceived lower efficacy as compared to opioids can hamper the market growth. Growing focus on development of advanced drug formulations, combination therapies, and neurostimulation devices present lucrative opportunities for major players in this industry.

Key Features of the Study:

This report provides an in-depth analysis of the global non opioid pain treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global non opioid pain treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Fresenius Kabi AG, GSK, Vertex Pharmaceuticals Incorporated, Pacira BioSciences, Collegium Pharmaceuticals, Cara Therapeutics, Akelos, Fidia Farmaceutici S.p.A., Sanofi, Eli Lilly and Company, Merck & Co, and Acorda Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global non opioid pain treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non opioid pain treatment market.

Detailed Segmentation:

Drug Type:
- Non-Steroidal Anti-Inflammatory Drugs
- Steriods
- Analgesics
- Corticosteroids
- Others
Indication:
- Musco Skeletal Disorders
- Central Nervous System Disorders
- Traumatic Pain
- Chronic Pain
- Others
Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- Fresenius Kabi AG
- GSK
- Vertex Pharmaceuticals Incorporated
- Pacira BioSciences
- Collegium Pharmaceuticals
- Cara Therapeutics
- Akelos
- Fidia Farmaceutici S.p.A.
- Sanofi
- Eli Lilly and Company
- Merck & Co
- Acorda Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot By Drug Type
- Market Snapshot By Indication
- Market Snapshot By Route of Administration
- Market Snapshot By Distribution Channel
- Market Snapshot By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Route of Administration Analysis
Reimbursement Scenario

4. Global Non Opioid Pain Treatment Market, By Drug Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Non-Steroidal Anti-Inflammatory Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Steriods, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics , 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Corticosteroids, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Non Opioid Pain Treatment Market, By Indication, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Musco Skeletal Disorders, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Central Nervous System Disorders, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Traumatic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Non Opioid Pain Treatment Market, By Route of Administration, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Topical, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Intravenous, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Oral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Non Opioid Pain Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Non Opioid Pain Treatment Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest Of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

9. Company Profiles - Global Non Opioid Pain Treatment Market

Pfizer Inc.
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Fresenius Kabi AG
GSK
Vertex Pharmaceuticals Incorporated
Pacira BioSciences
Collegium Pharmaceuticals
Cara Therapeutics
Akelos
Fidia Farmaceutici S.p.A.
Sanofi
Eli Lilly and Company
Merck & Co
Acorda Therapeutics
Hyloris Pharmaceuticals
Hikma Pharmaceuticals PLC